These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 8712768)

  • 1. The cardiac ion channels: relevance to management of arrhythmias.
    Roden DM; George AL
    Annu Rev Med; 1996; 47():135-48. PubMed ID: 8712768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Classification and mechanism of action of anti-arrhythmia drugs].
    Gasic S
    Wien Med Wochenschr; 1994; 144(14-15):338-42. PubMed ID: 7825324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cardiac two-pore-domain potassium channels (K2P): Physiology, pharmacology, and therapeutic potential].
    Schmidt C; Wiedmann F; Schweizer PA; Katus HA; Thomas D
    Dtsch Med Wochenschr; 2012 Aug; 137(33):1654-8. PubMed ID: 22875694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [New aspects of the molecular effect of anti-arrhythmia agents].
    Honerjäger P
    Herz; 1990 Apr; 15(2):70-8. PubMed ID: 2160907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacotherapy of cardiac arrhythmias--basic science for clinicians.
    Shu J; Zhou J; Patel C; Yan GX
    Pacing Clin Electrophysiol; 2009 Nov; 32(11):1454-65. PubMed ID: 19744278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Ion channels and arrhythmias].
    Borchard U; Hafner D
    Z Kardiol; 2000; 89 Suppl 3():6-12. PubMed ID: 10810780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac electrophysiological effects of nitric oxide.
    Tamargo J; Caballero R; Gómez R; Delpón E
    Cardiovasc Res; 2010 Sep; 87(4):593-600. PubMed ID: 20587506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [New fields of research in pharmacological antiarrhythmic therapy].
    Hatem S
    Arch Mal Coeur Vaiss; 2004 Nov; 97(11):1054-7. PubMed ID: 15609906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postrepolarization refractoriness in acute ischemia and after antiarrhythmic drug administration: action potential duration is not always an index of the refractory period.
    Coronel R; Janse MJ; Opthof T; Wilde AA; Taggart P
    Heart Rhythm; 2012 Jun; 9(6):977-82. PubMed ID: 22293142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ["Sicilian gambit": pathophysiological approach to drug therapy of arrhythmia (lecture]].
    Sulimov VA
    Ter Arkh; 1999; 71(8):67-74. PubMed ID: 10515042
    [No Abstract]   [Full Text] [Related]  

  • 11. Future of antiarrhythmic drugs.
    Darbar D; Roden DM
    Curr Opin Cardiol; 2006 Jul; 21(4):361-7. PubMed ID: 16755206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cellular effects of anti-arrhythmia drugs. Their predictive value of therapeutic effects].
    Motté G
    Arch Mal Coeur Vaiss; 1981 Dec; 74 Spec No():7-16. PubMed ID: 6280631
    [No Abstract]   [Full Text] [Related]  

  • 13. [Anti-arrhythmia drugs in geriatric patients].
    Hohnloser SH; Zabel M
    Fortschr Med; 1991 Aug; 109(25):492-5. PubMed ID: 1937335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modernized Classification of Cardiac Antiarrhythmic Drugs.
    Lei M; Wu L; Terrar DA; Huang CL
    Circulation; 2018 Oct; 138(17):1879-1896. PubMed ID: 30354657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Arrhythmias and heart failure].
    Amann FW; Candinas R
    Ther Umsch; 1993 Jun; 50(6):419-24. PubMed ID: 8351673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Ischemic disorders of cardiac rhythm: effects of the autonomic nervous system on electrophysiologic findings and pharmacotherapy].
    Gülker H; Thale J
    Z Kardiol; 1986; 75 Suppl 5():15-34. PubMed ID: 3825228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Principles for the classification of anti-arrhythmia agents in cardiac arrhythmias].
    Ravens U
    Z Kardiol; 1992; 81 Suppl 4():119-25. PubMed ID: 1290288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac ion channels.
    Roden DM; Balser JR; George AL; Anderson ME
    Annu Rev Physiol; 2002; 64():431-75. PubMed ID: 11826275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiarrhythmic agents: current status and perspectives.
    Mátyus P; Varró A; Papp JG; Wamhoff H; Varga I; Virág L
    Med Res Rev; 1997 Sep; 17(5):427-51. PubMed ID: 9276860
    [No Abstract]   [Full Text] [Related]  

  • 20. Electrophysiologic changes in heart failure: focus on pacemaker channels.
    Sartiani L; Stillitano F; Cerbai E; Mugelli A
    Can J Physiol Pharmacol; 2009 Feb; 87(2):84-90. PubMed ID: 19234571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.